- Home
- GPOR vs KTTA Comparison
GPOR vs KTTA Comparison
Compare GPOR & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPOR
- KTTA
- Stock Information
- Founded
- GPOR 1997
- KTTA 2020
- Country
- GPOR United States
- KTTA United States
- Employees
- GPOR N/A
- KTTA N/A
- Industry
- GPOR Oil & Gas Production
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- GPOR Energy
- KTTA Health Care
- Exchange
- GPOR Nasdaq
- KTTA Nasdaq
- Market Cap
- GPOR 3.4B
- KTTA 5.5M
- IPO Year
- GPOR N/A
- KTTA 2021
- Fundamental
- Price
- GPOR $184.45
- KTTA $0.68
- Analyst Decision
- GPOR Buy
- KTTA
- Analyst Count
- GPOR 8
- KTTA 0
- Target Price
- GPOR $214.50
- KTTA N/A
- AVG Volume (30 Days)
- GPOR 294.5K
- KTTA 142.8K
- Earning Date
- GPOR 08-05-2025
- KTTA 08-12-2025
- Dividend Yield
- GPOR N/A
- KTTA N/A
- EPS Growth
- GPOR N/A
- KTTA N/A
- EPS
- GPOR N/A
- KTTA N/A
- Revenue
- GPOR $1,014,317,000.00
- KTTA N/A
- Revenue This Year
- GPOR $56.18
- KTTA N/A
- Revenue Next Year
- GPOR $13.45
- KTTA N/A
- P/E Ratio
- GPOR N/A
- KTTA N/A
- Revenue Growth
- GPOR 11.01
- KTTA N/A
- 52 Week Low
- GPOR $130.02
- KTTA $0.67
- 52 Week High
- GPOR $210.32
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- GPOR 43.60
- KTTA 32.67
- Support Level
- GPOR $170.24
- KTTA $0.67
- Resistance Level
- GPOR $206.29
- KTTA $0.77
- Average True Range (ATR)
- GPOR 6.63
- KTTA 0.04
- MACD
- GPOR -2.54
- KTTA 0.01
- Stochastic Oscillator
- GPOR 35.49
- KTTA 14.02
About GPOR Gulfport Energy Corporation
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).